Health News
Insight: GSK vaccine ingredient scrutinized for narcolepsy clues
LONDON - Mounting evidence of a link between GlaxoSmithKline's Pandemrix flu shot and a spike in narcolepsy cases among children in Europe is putting one of the vaccine's key ingredients, AS03, under intense scrutiny.
Slow and steady can win the diet drug race
- Vivus Inc, vying to create the world's first billion-dollar weight-loss pill, is taking a cautious approach to marketing in an attempt to overcome the skepticism, safety concerns and lawsuits that have dogged the diet drug industry.
Tranzyme to explore strategic options
- Drugmaker Tranzyme Inc said it will explore strategic options, including a sale, less than two months after it stopped the second mid-stage trial of its drug for stomach paralysis.
Longer span between mammograms okay for older women
NEW YORK (Reuters Health) - Screening women over 65 each year for breast cancer doesn't catch any more early tumors - but it does lead to more false positives - than screening every other year, according to a new study.
Test strip supply linked to better diabetes care
NEW YORK (Reuters Health) - Frequent blood sugar testing was strongly associated with better diabetes control in a large new study that concludes public and private insurers should not be limiting test strip supplies.
Catholic bishops reject Obama offer on contraceptive coverage
WASHINGTON - U.S. Roman Catholic bishops on Thursday rejected the Obama Administration's latest bid for compromise over a hotly disputed health policy that requires employees at religiously affiliated institutions to have access to insurance coverage for contraceptives.
FDA outlines path to test Alzheimer's drugs earlier
CHICAGO - Proposed U.S. guidelines may make it easier for drug companies to test Alzheimer's treatments in people at an earlier stage, when scientists think they may have the best shot at working.
Appeals court upholds patent on Merck's Vytorin
WASHINGTON - The patent on Merck & Co's cholesterol fighters Zetia and Vytorin, two of the drugmaker's biggest products, is valid, a U.S. appeals court ruled on Thursday.
Senators push to repeal U.S. medical device tax; success unlikely
WASHINGTON - A bipartisan group of U.S. senators introduced legislation on Thursday to repeal a tax on medical devices that is part of President Barack Obama's healthcare law, although the proposal likely faces an uphill climb in Congress.
Birth defects in multiples on the rise: study
NEW YORK (Reuters Health) - The number of birth defects among twins and triplets increased nearly two-fold in 14 European countries between 1984 and 2007, according to a new study.
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
